Faecal transplant for irritable bowel syndrome does not improve symptoms at 12 weeks, but route of administration may play a part, a systematic review and meta-analysis suggests.

Pooling data from four randomised controlled trials with 254 participants, the US authors found no difference between people given a faecal microbiota transplant (FMT) and those given placebo.